Business
Vivos Therapeutics Announces Registration with Health Canada to Manufacture and Sell Sleep Disorder, Snoring and Sleep Apnea Appliances to Canadian Dentists
HIGHLANDS RANCH, Colo., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company
About this update from Vivos Therapeutics, Inc.
[{"type":"text","content":"HIGHLANDS RANCH, Colo., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (OSA) and snoring, today announced its official registration with Health Canada, a Minister of Health department responsible for helping Canadians maintain and improve their health through services and resources. The official registration of Vivos products will aim to provide patients with a comprehensive, end-to-end solution for OSA patients, which incorporates clinical screening, medical diagnosis and therapy using Vivos products. At the core of this development, the Company will offer its comprehensive line of highly effective oral appliances and proprietary clinical protocols to approximately 25,000 dentists across Canada who have millions of patients in search of a solution to sleep related disorders, snoring and OSA. “With Vivos Therapeutics as an official partner of Health Canada, local dentists will now be able to screen, clinically assess and properly treat patients suffering from OSA through complete and official access to the Vivos System. For years, the demand from Canadian dentists for our revolutionary line of products has been high, and now with this new development we can move aggressively to provide them with the full measure of clinical and practice management education to seamlessly deliver our much-needed products to millions of Canadians suffering from OSA and its related comorbidities,” said Kirk Huntsman, Vivos Chairman and CEO. In connection with this regulatory development, Vivos expects to expand its contract manufacturing presence and capacity in Canada to better serve the needs of Canadian dentists and their patients. “As lead dentist at Avalon Dental and investigator for a Vivos WCG IRB pediatric clinical trial, I have spent years trying to find an alternative treatment for my patients who suffer from a range of sleep disorders. With the Vivos System, I am finally able to officially prescribe the latest therapeutic protocol and technology that I am confident will improve my patient’s clinical outcomes,” said Dr. Tammarie Heit of Edmonton, Alberta, Canada. About Vivos Therapeutics, Inc. Vivos T...